Undisclosed CD25 chimeric aptamer / Aptamer Sci, Korea Advanced Institute of Science and Technology - LARVOL DELTA

The world's top three cancer societies 'AACR' opens next month… K-Bio gun dispatch (Newsis) - "Curocell will also present the research results of CAR-T treatment for the treatment of T-cell (immune cell) lymphoma....ViGencell is also planning to release animal test data to evaluate the efficacy of antigen-targeting CAR-T. Therapex plans to introduce the preclinical results of 'TRX-221', a candidate for lung cancer treatment....Aptamer Science will present the research results of 'CD25-ApDC Immuno-Oncology'."

Preclinical • Hematological Malignancies • Lung Cancer • Lymphoma • Oncology • Solid Tumor